Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
J Biol Chem ; 276(18): 14773-83, 2001 May 04.
Article in English | MEDLINE | ID: mdl-11279013

ABSTRACT

Drosophila nucleosome remodeling factor (NURF) is an ISWI-containing protein complex that facilitates nucleosome mobility and transcriptional activation in an ATP-dependent manner. Numerous studies have implicated histone acetylation in transcriptional activation. We investigated the relative contributions of these two chromatin modifications to transcription in vitro of a chromatinized adenovirus E4 minimal promoter that contains binding sites for the GAL4-VP16 activator. We found that NURF could remodel chromatin and stimulate transcription irrespective of the acetylation status of histones. In contrast, hyperacetylation of histones in the absence of NURF was unable to stimulate transcription, suggesting that NURF-dependent chromatin remodeling is an obligatory step in E4 promoter activation. When chromatin templates were first hyperacetylated and then incubated with NURF, significantly greater transcription stimulation was observed. The results suggest that changes in chromatin induced by acetylation of histones and the mobilization of nucleosomes by NURF combine synergistically to facilitate transcription. Experiments using single and multiple rounds of transcription indicate that these chromatin modifications stimulate transcription preinitiation as well as reinitiation.


Subject(s)
Adenosine Triphosphate/metabolism , Chromatin/genetics , Histones/metabolism , Nucleosomes/metabolism , Transcription, Genetic , Acetylation , Animals , Drosophila
2.
J Electron Microsc (Tokyo) ; 49(3): 415-21, 2000.
Article in English | MEDLINE | ID: mdl-11108029

ABSTRACT

Among many scanning probe microscopies, atomic force microscopy (AFM) is a useful technique to analyse the structure of biological materials because of its applicability to non-conductors in physiological conditions with high resolution. However, the resolution has been limited to an inherent property of the technique; tip effect associated with a large radius of the scanning probe. To overcome this problem, we developed a carbon nanotube probe by attaching a carbon nanotube to a conventional scanning probe under a well-controlled process. Because of the constant and small radius of the tip (2.5-10 nm) and the high aspect ratio (1:100) of the carbon nanotube, the lateral resolution has been much improved judging from the apparent widths of DNA and nucleosomes. The carbon nanotube probes also possessed a higher durability than the conventional probes. We further evaluated the quality of carbon nanotube probes by three parameters to find out the best condition for AFM imaging: the angle to the tip axis; the length; and the tight fixation to the conventional tip. These carbon nanotube probes, with high vertical resolution, enabled us to clearly visualize the subunit organization of multi-subunit proteins and to propose structural models for proliferating cell nuclear antigen and replication factor C. This success in the application of carbon nanotube probes provides the current AFM technology with an additional power for the analyses of the detailed structure of biological materials and the relationship between the structure and function of proteins.


Subject(s)
DNA-Binding Proteins/ultrastructure , Homeodomain Proteins , Microscopy, Atomic Force/instrumentation , Nucleosomes/ultrastructure , Proliferating Cell Nuclear Antigen/ultrastructure , Proto-Oncogene Proteins c-bcl-2 , Repressor Proteins , Saccharomyces cerevisiae Proteins , Carbon , Minor Histocompatibility Antigens , Models, Molecular , Replication Protein C
3.
Nature ; 406(6795): 541-4, 2000 Aug 03.
Article in English | MEDLINE | ID: mdl-10952318

ABSTRACT

The packaging of the eukaryotic genome in chromatin presents barriers that restrict the access of enzymes that process DNA. To overcome these barriers, cells possess a number of multi-protein, ATP-dependent chromatin remodelling complexes, each containing an ATPase subunit from the SNF2/SWI2 superfamily. Chromatin remodelling complexes function by increasing nucleosome mobility and are clearly implicated in transcription. Here we have analysed SNF2/SWI2- and ISWI-related proteins to identify remodelling complexes that potentially assist other DNA transactions. We purified a complex from Saccharomyces cerevisiae that contains the Ino80 ATPase. The INO80 complex contains about 12 polypeptides including two proteins related to the bacterial RuvB DNA helicase, which catalyses branch migration of Holliday junctions. The purified complex remodels chromatin, facilitates transcription in vitro and displays 3' to 5' DNA helicase activity. Mutants of ino80 show hypersensitivity to agents that cause DNA damage, in addition to defects in transcription. These results indicate that chromatin remodelling driven by the Ino80 ATPase may be connected to transcription as well as DNA damage repair.


Subject(s)
Adenosine Triphosphatases/metabolism , Chromatin/physiology , DNA, Fungal/metabolism , DNA-Binding Proteins/metabolism , Nuclear Proteins , Saccharomyces cerevisiae/metabolism , Transcription Factors/metabolism , Transcription, Genetic , Adenosine Triphosphatases/genetics , Chromatin/chemistry , Cloning, Molecular , DNA-Binding Proteins/genetics , Fungal Proteins/genetics , Fungal Proteins/physiology , Macromolecular Substances , Mutation , Peptides/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins , Transcription Factors/genetics
6.
Mol Cell ; 1(1): 141-50, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9659911

ABSTRACT

The Drosophila nucleosome remodeling factor (NURF) is a protein complex of four subunits that assists transcription factor-mediated perturbation of nucleosomes in an ATP-dependent manner. We have investigated the role of NURF in activating transcription from a preassembled chromatin template and have found that NURF is able to facilitate transcription mediated by a GAL4 derivative carrying both a DNA binding and an activator domain. Interestingly, once nucleosome remodeling by the DNA binding factor is accomplished, a high level of NURF activity is not continuously required for recruitment of the general transcriptional machinery and transcription for at least 100 nucleotides. Our results provide direct evidence that NURF is able to assist gene activation in a chromatin context, and identify a stage of NURF dependence early in the process leading to transcriptional initiation.


Subject(s)
Chromatin/genetics , Chromosomal Proteins, Non-Histone , Drosophila Proteins , Drosophila/genetics , Insect Proteins/metabolism , Molecular Chaperones , Nuclear Proteins , Nucleosomes/genetics , Transcriptional Activation/physiology , Adenosine Triphosphatases/genetics , Adenosine Triphosphatases/metabolism , Adenosine Triphosphate/metabolism , Animals , Chromatin/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , DNA-Binding Proteins/pharmacology , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Heat Shock Transcription Factors , Insect Proteins/genetics , Nucleosomes/metabolism , Retinoblastoma-Binding Protein 4 , Saccharomyces cerevisiae Proteins , Transcription Factors/genetics , Transcription Factors/metabolism , Transcription Factors/pharmacology , Transcriptional Activation/drug effects
8.
J Biol Chem ; 270(16): 9384-9, 1995 Apr 21.
Article in English | MEDLINE | ID: mdl-7721862

ABSTRACT

The c-myb proto-oncogene product (c-Myb) is a transcriptional activator that can bind to the specific DNA sequences. Although c-Myb also represses an artificial promoter containing the Myb binding sites, natural target genes transcriptionally repressed by c-Myb have not been identified. We have found that the human c-erbB-2 promoter activity is repressed by c-Myb or B-Myb in a chloramphenicol acetyltransferase co-transfection assay. Domain analyses of c-Myb suggested that Myb represses the c-erbB-2 promoter activity by competing with positive regulators of the c-erbB-2 promoter. In in vitro transcription assays, Myb proteins containing only the DNA binding domain could repress c-erbB-2 promoter activity. Two Myb binding sites in the c-erbB-2 promoter were critical for transcriptional repression by c-Myb. One of the two Myb binding sites overlaps the TATA box, and DNase I footprint analyses indicated that c-Myb can compete with TFIID. These results suggest that Myb-induced trans-repression of the c-erbB-2 promoter partly involves competition between Myb and TFIID.


Subject(s)
Promoter Regions, Genetic , Proto-Oncogene Proteins/physiology , Receptor, ErbB-2/genetics , Repressor Proteins/physiology , Base Sequence , Binding Sites , Binding, Competitive , Molecular Sequence Data , Proto-Oncogene Mas , Proto-Oncogene Proteins c-myb , Proto-Oncogenes
9.
FEBS Lett ; 348(1): 80-8, 1994 Jul 04.
Article in English | MEDLINE | ID: mdl-7913049

ABSTRACT

Transcription of the human c-erbB-2-proto-oncogene starts mainly at two sites, nucleotide positions +1 and -69. The present studies have identified an initiator-like element that specifies the position of transcription initiation at position -69. This initiator-like element contains six GGA repeats and is located just downstream from the transcription start site between positions -68 and -45. In addition, both in vitro and in vivo studies indicated that transcription initiation at position +1 is specified by a TATA box 25 bp upstream from the transcription startpoint. Thus, initiation at two sites in the c-erbB-2 promoter is controlled independently by the initiator-like element and the TATA box.


Subject(s)
ErbB Receptors/genetics , Gene Expression Regulation , Proto-Oncogene Proteins/genetics , TATA Box , Base Sequence , DNA , HeLa Cells , Humans , Molecular Sequence Data , Proto-Oncogene Mas , Receptor, ErbB-2 , Transcription Factor TFIID , Transcription Factors/metabolism , Transcription, Genetic
10.
Oncogene ; 7(6): 1233-40, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1594249

ABSTRACT

To identify the target genes modulated by the myb gene product (Myb), a co-transfection assay with a Myb expression plasmid was performed. Both c-Myb and B-Myb, another member of the myb gene family, trans-activated the human c-myc promoter. DNAase I footprint analysis using the bacterially expressed c-Myb, identified multiple c-Myb binding sites in the c-myc promoter region. Deletion analysis of the c-myc promoter suggested that some number of Myb binding sites, not a specific Myb binding site, is important for the c-Myb-induced trans-activation of the c-myc promoter. Using the c-myc-chloramphenicol acetyltransferase (CAT) construct as a reporter in a co-transfection assay, the domains of c-Myb required for trans-activation were examined. The functional domains of c-Myb identified using the c-myc promoter were almost the same as those identified previously with the artificial target gene containing Myb binding sites, but unlike the case with the artificial target gene the N-terminal half of the previously identified negative regulatory domains and the C-terminal 136 amino acids were required for the maximal trans-activation of the c-myc promoter. These results indicate that there are some differences in the regulation of Myb-dependent trans-activation in different target genes.


Subject(s)
DNA-Binding Proteins/metabolism , Genes, myc , Oncogenes , Promoter Regions, Genetic , Proto-Oncogene Proteins/metabolism , Transcription, Genetic , Transcriptional Activation , Animals , Base Sequence , Cell Line , Chloramphenicol O-Acetyltransferase/genetics , Chloramphenicol O-Acetyltransferase/metabolism , Chromosome Deletion , DNA-Binding Proteins/genetics , Humans , Molecular Sequence Data , Oligodeoxyribonucleotides , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-myb , Recombinant Fusion Proteins/metabolism , Sequence Homology, Nucleic Acid , Transfection
11.
Proc Natl Acad Sci U S A ; 89(12): 5403-7, 1992 Jun 15.
Article in English | MEDLINE | ID: mdl-1535157

ABSTRACT

The wild-type p53 protein suppresses transformation, but certain missense mutants of p53 can transform cells. Although the wild-type p53 protein contains a transcriptional activation domain, no p53-responsive element has been identified. Here, we identified the p53-responsive element within the Tax-responsive element [21-base-pair (bp) enhancer] of human T-cell leukemia virus type I. Mutation analysis of the 21-bp enhancer indicated that the 16-bp sequence containing the cAMP-responsive element and its surrounding sequence was responsible for p53-induced transactivation. This 16-bp sequence was demonstrated to bind specifically to wild-type human p53 protein in vitro. Using a series of deletion mutants of p53, we showed that almost the entire region of p53 is needed for the transactivating capacity. Furthermore, the transforming mutants of p53 were unable to act as transcriptional activators. The p53-responsive element identified here should be useful to analyze the mechanism by which p53 regulates expression of a set of genes with a negative effect on cellular growth.


Subject(s)
DNA-Binding Proteins/metabolism , Enhancer Elements, Genetic , Genes, p53 , Human T-lymphotropic virus 1/genetics , Mutagenesis, Site-Directed , Transcriptional Activation , Tumor Suppressor Protein p53/metabolism , Animals , Base Sequence , Cell Line , Chloramphenicol O-Acetyltransferase/genetics , Chloramphenicol O-Acetyltransferase/metabolism , Chromosome Deletion , Cyclic AMP Response Element-Binding Protein , DNA-Binding Proteins/genetics , Genes, ras , Humans , Molecular Sequence Data , Oligodeoxyribonucleotides , Promoter Regions, Genetic , Transfection , Tumor Suppressor Protein p53/genetics
12.
J Biol Chem ; 265(16): 9280-4, 1990 Jun 05.
Article in English | MEDLINE | ID: mdl-2160970

ABSTRACT

Three members of the myb gene family have been identified in human cDNA libraries c-myb, A-myb, and B-myb. We compared the DNA binding properties of the B-myb and c-myb proteins (B-MYB and c-MYB) using bacterially synthesized B-MYB and c-MYB in DNase I footprinting. B-MYB bound to most of the c-MYB binding sites examined, including the c-MYB binding site, MBS-I, in the simian virus (SV) 40 enhancer, in which the most frequent sequence was CCTAACTG. The MBS-I site was an enhancer element dependent on B-MYB and c-MYB in a co-transfection assay that used the B-myb or c-myb expression plasmid. Some sites in the SV40 genome, including the MBS-BI site, had high affinity with B-MYB but little or no affinity with c-MYB, in which the most frequent sequence was AGAAANPyrG. The MBS-BI site was an enhancer element dependent on B-MYB and a very weakly dependent on c-MYB. Our results showed that B-MYB is a transcriptional activator, like c-MYB, and that although B-MYB and c-MYB have similar sequence specificity for DNA binding some sequences were recognized by B-MYB preferentially.


Subject(s)
Cell Cycle Proteins , DNA-Binding Proteins/metabolism , DNA/metabolism , Proto-Oncogene Proteins/metabolism , Trans-Activators , Transcription Factors/metabolism , Transcription, Genetic , Base Sequence , Binding Sites , DNA-Binding Proteins/genetics , Deoxyribonuclease I , Enhancer Elements, Genetic/genetics , Escherichia coli/genetics , Genes, Viral , Globins/genetics , Humans , Molecular Sequence Data , Plasmids , Promoter Regions, Genetic/genetics , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-myb , Recombinant Proteins/metabolism , Simian virus 40/genetics , Transcription Factors/genetics , Transfection
13.
Nucleic Acids Res ; 18(2): 337-43, 1990 Jan 25.
Article in English | MEDLINE | ID: mdl-2183181

ABSTRACT

We identified the human c-ski gene product (c-Ski) as a protein with the apparent molecular weight of 100,000, p100c-ski, by using a c-Ski-specific polyclonal antibody. p100c-ski was a nuclear protein and p100c-ski in nuclear extracts of Molt4 cells bound to calf thymus DNA cellulose, but the bacterially synthesized c-Ski did not, suggesting that Ski was associated with another protein(s) and that the Ski complex had DNA-binding activity. This hypothesis was supported by the finding that the bacterially synthesized Ski bounds to DNA cellulose after being mixed with a nuclear extract of Molt4 cells. By use of a series of deletion mutants of Ski synthesized in an in vitro translation system, two portions in Ski were found to be necessary for the DNA binding of the Ski complex: the N-proximal portion containing a cystein/histidine-rich domain and the C-terminal portion including a region rich in basic amino acids.


Subject(s)
DNA-Binding Proteins/metabolism , Nuclear Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Proto-Oncogenes , Chromosome Deletion , DNA-Binding Proteins/genetics , DNA-Binding Proteins/isolation & purification , Escherichia coli/genetics , Genetic Vectors , Humans , Mutation , Nuclear Proteins/isolation & purification , Protein Biosynthesis , Proto-Oncogene Mas , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/isolation & purification , RNA, Messenger/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Restriction Mapping
SELECTION OF CITATIONS
SEARCH DETAIL
...